Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

UroGen Pharma (URGN) Interest Coverage Ratio (2019 - 2023)

UroGen Pharma's Interest Coverage Ratio history spans 5 years, with the latest figure at 0.1 for Q4 2023.

  • For Q4 2023, Interest Coverage Ratio fell 138.89% year-over-year to 0.1; the TTM value through Dec 2023 reached 0.46, down 138.1%, while the annual FY2023 figure was 0.46, 138.1% down from the prior year.
  • Interest Coverage Ratio reached 0.1 in Q4 2023 per URGN's latest filing, down from 0.26 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 0.26 in Q4 2022 to a low of 0.79 in Q4 2019.
  • Average Interest Coverage Ratio over 5 years is 0.24, with a median of 0.2 recorded in 2021.
  • Peak YoY movement for Interest Coverage Ratio: skyrocketed 232.2% in 2022, then plummeted 138.89% in 2023.
  • A 5-year view of Interest Coverage Ratio shows it stood at 0.79 in 2019, then soared by 55.03% to 0.35 in 2020, then soared by 44.11% to 0.2 in 2021, then skyrocketed by 232.2% to 0.26 in 2022, then tumbled by 138.89% to 0.1 in 2023.
  • Per Business Quant, the three most recent readings for URGN's Interest Coverage Ratio are 0.1 (Q4 2023), 0.26 (Q4 2022), and 0.2 (Q4 2021).